Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

Year
2024
Data d'inici
Data de tancament
Descripció
Data Entry_20240071
Codi
2024-71
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Study Coordinator Clinical Trial Unit / Rheumatology Research Group_20240072
Codi
2024-72
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Finance Administrative_20240067
Codi
2024-67
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Licensed Research Technician Neurodegenerative Diseases Research Group_20240068
Codi
2024-68
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Postdoctoral Researcher - Therapeutics and innovation in neuropediatrics_20240065
Codi
2024-65
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
International Pre-Award Research Manager (Grant Writer)_20240066
Codi
2024-66
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Administrative
Codi
2024-64
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Innovation Support_20240060
Codi
2024-60
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Junior Innovation Manager_20240061
Codi
2024-61
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Laboratory Technician Diabetes and Metabolism Research Group_20240062
Codi
2024-62
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Senior Innovation Manager_20240063
Codi
2024-63
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Administrative Assistant Rheumatology Research Group - IMID-Biobank_20240059
Codi
2024-59
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Communication Technician - Maternity leave_20240058
Codi
2024-58
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Communication and Dissemination Manager_20240056
Codi
2024-56
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Study Coordinator - Neurovascular diseases group_20240057
Codi
2024-57
Reclutant
Inactiu

Estudio de fase 2 de la infusión de células T autólogas, diferenciadas y de sangre periférica expandidas y transducidas con un lentivirus para expresar un receptor de antígeno quimérico con especificidad anti-CD19 (A3B1) junto con regiones coestimuladoras 4-1BB y CD3z (ARI- 0001 células) en niños y adolescentes (de 0 a 18 años) con leucemia linfoblástica aguda CD19+ resistente o refractaria al tratamiento

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Estudio de fase 2a, aleatorizado, doble ciego y controlado con placebo para evaluar la seguridad y la tolerabilidad, la farmacocinética, la farmacodinamia y la eficacia preliminar del setanaxib, un inhibidor de NOX1/4, en pacientes con síndrome de Alport

  • Protocol code: GSN000500
  • EudraCT code: No aplica
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Principal investigator:  Agraz Pamplona, Irene
  • Research group:  Nefrologia i trasplantament renal
  • Service: Nefrologia
  • Phase: Phase II
  • Recruiting: Open
  • Status: Tancat

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

A phase 3, randomized, double-blind, placebo-controlled, parallel-arm study to evaluate the efficacy and safety of RZ358 in patients with congenital hyperinsulinism.

  • Protocol code: RZ358-301
  • EudraCT code: _
  • Pathology: Malalties endocrines, nutricionals i metabòliques
  • Principal investigator:  Clemente Leon, Maria
  • Research group:  Creixement i desenvolupament
  • Service: Pediatria General i Especialitats
  • Phase: Fase III
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Estudio Fase 3, multicéntrico, aleatorizado, doble ciego, controlado con placebo para determinar la eficacia y seguridad de BIIB122/DNL151 en participantes con Enfermedad de Parkinson y variantes patógenas de LRRK2

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

ESTUDIO MULTICENTRO DE CONTINUACIÓN EN DOS PARTES, ALEATORIZADO, CONTROLADO CON PLACEBO, DOBLE CIEGO PARA INVESTIGAR LA SEGURIDAD, TOLERABILIDAD, FARMACOCINÉTICA, FARMACODINÁMICA Y EFICACIA DE RO7204239 EN COMBINACIÓN CON RISDIPLAM (RO7034067) EN PACIENTES CON ATROFIA MUSCULAR ESPINAL

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.